WOCKPHARMANSEWockhardt Limited· PharmaceuticalsMinimalNeutral
Announced Thu, 9 Apr · 15:19 IST

Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, please findenclosed the Certificate received from MUFG Intime India Private Limited, Registrar and Share Transfer Agent of the Company for the quarter ended 31st March, 2026.

WOCKPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.4%1-day move
₹1350.00
prior close
₹1369.40
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.3-0.4+0.9+0.1+0.9+3.2+3.9+6.0+20.4+39.7+35.9
Up moveDown movePending
AI summary

Wockhardt Limited has filed a routine compliance certificate from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited, for the quarter ended 31st March 2026. The certificate confirms that all securities received from depository participants for dematerialisation were properly processed, confirmed or rejected, and listed on the relevant stock exchanges. It also verifies that physical share certificates submitted for dematerialisation were mutilated and cancelled after verification, and depositories were substituted as registered owners in the register of members within the prescribed timelines. This is a standard regulatory filing required under SEBI regulations.

Likely market impact

No material impact on shareholders or stock price. This is a routine procedural filing confirming proper handling of share dematerialisation requests during the quarter.